Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)
INR 56.84
(0.0%)
INR 56.84
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 32.24 Million INR | -26.06% |
| 2022 | 43.6 Million INR | 30.56% |
| 2021 | 33.4 Million INR | 0.0% |
| 2020 | - INR | -100.0% |
| 2019 | 191.17 Thousand INR | -50.52% |
| 2018 | 386.38 Thousand INR | -31.49% |
| 2017 | 563.94 Thousand INR | -22.26% |
| 2016 | 725.46 Thousand INR | -17.12% |
| 2015 | 875.36 Thousand INR | 0.0% |
| 2014 | - INR | -100.0% |
| 2013 | 142.01 Thousand INR | -91.61% |
| 2012 | 1.69 Million INR | 885.53% |
| 2011 | 171.81 Thousand INR | -99.48% |
| 2010 | 32.94 Million INR | -24.69% |
| 2009 | 43.74 Million INR | 191.0% |
| 2008 | 15.03 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 32.24 Million INR | -26.06% |
| 2023 Q2 | 38.03 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 32.24 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 43.6 Million INR | 30.56% |
| 2022 Q4 | 43.6 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 32.47 Million INR | 0.0% |
| 2021 Q2 | - INR | 0.0% |
| 2021 Q4 | 33.4 Million INR | 0.0% |
| 2021 Q1 | - INR | 0.0% |
| 2021 Q3 | - INR | 0.0% |
| 2021 FY | 33.4 Million INR | 0.0% |
| 2020 FY | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | - INR | 0.0% |
| 2020 Q4 | - INR | 0.0% |
| 2019 Q3 | - INR | 0.0% |
| 2019 FY | 191.17 Thousand INR | -50.52% |
| 2019 Q4 | 191.17 Thousand INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | - INR | 0.0% |
| 2018 FY | 386.38 Thousand INR | -31.49% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 386.38 Thousand INR | 0.0% |
| 2017 Q4 | 563.94 Thousand INR | 0.0% |
| 2017 FY | 563.94 Thousand INR | -22.26% |
| 2017 Q3 | - INR | 0.0% |
| 2016 Q4 | 725.46 Thousand INR | 0.0% |
| 2016 FY | 725.46 Thousand INR | -17.12% |
| 2015 FY | 875.36 Thousand INR | 0.0% |
| 2015 Q4 | 875.36 Thousand INR | 0.0% |
| 2014 FY | - INR | -100.0% |
| 2014 Q4 | - INR | 0.0% |
| 2013 FY | 142.01 Thousand INR | -91.61% |
| 2013 Q4 | 142.01 Thousand INR | 0.0% |
| 2012 FY | 1.69 Million INR | 885.53% |
| 2012 Q4 | 1.69 Million INR | 0.0% |
| 2011 Q4 | 171.81 Thousand INR | 0.0% |
| 2011 FY | 171.81 Thousand INR | -99.48% |
| 2010 FY | 32.94 Million INR | -24.69% |
| 2009 FY | 43.74 Million INR | 191.0% |
| 2008 FY | 15.03 Million INR | 0.0% |
| 2008 Q4 | 15.03 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 265.79 Million INR | 87.869% |
| Ind-Swift Limited | 10.09 Billion INR | 99.681% |
| Bajaj HealthCare Limited | 650.34 Million INR | 95.042% |
| Sakar Healthcare Limited | 549.55 Million INR | 94.133% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 99.849% |
| Innova Captab Limited | 2.1 Billion INR | 98.468% |
| Divi's Laboratories Limited | 20 Million INR | -61.219% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -15.835% |
| Morepen Laboratories Limited | 33.64 Million INR | 4.151% |
| Mankind Pharma Limited | 325.81 Million INR | 90.104% |
| Sequent Scientific Limited | 1.42 Billion INR | 97.741% |
| Wanbury Limited | 820 Million INR | 96.068% |
| Laurus Labs Limited | 7.98 Billion INR | 99.596% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 97.702% |
| Glenmark Life Sciences Limited | 147.61 Million INR | 78.156% |
| Alembic Limited | 73.9 Million INR | 56.368% |
| Hikal Limited | 4.22 Billion INR | 99.237% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 94.872% |
| Neuland Laboratories Limited | 449.2 Million INR | 92.822% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | 86.361% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 97.874% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Themis Medicare Limited | 267.74 Million INR | 87.957% |
| RPG Life Sciences Limited | -30.3 Million INR | 206.415% |
| Zydus Lifesciences Limited | 251 Million INR | 87.154% |
| Lupin Limited | 1.55 Billion INR | 97.924% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -130.84% |
| Wockhardt Limited | 8.91 Billion INR | 99.638% |
| Vaishali Pharma Limited | 35.98 Million INR | 10.392% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -7960.942% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | 57.333% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 99.898% |
| FDC Limited | 2.46 Million INR | -1207.533% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 99.462% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 99.507% |
| Venus Remedies Limited | 386.8 Million INR | 91.664% |
| ZIM Laboratories Limited | 356 Million INR | 90.943% |
| Bliss GVS Pharma Limited | 355.92 Million INR | 90.941% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -250.476% |
| Shilpa Medicare Limited | 5.6 Billion INR | 99.424% |
| Albert David Limited | 6.01 Million INR | -435.967% |
| Ajanta Pharma Limited | 235.2 Million INR | 86.291% |
| Hester Biosciences Limited | 1.81 Billion INR | 98.226% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | 84.816% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | 97.254% |
| Gufic Biosciences Limited | 1.53 Billion INR | 97.906% |
| Windlas Biotech Limited | 20.18 Million INR | -59.781% |
| Procter & Gamble Health Limited | 68.8 Million INR | 53.134% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | 75.855% |
| Granules India Limited | 689.71 Million INR | 95.325% |
| Aarti Drugs Limited | 2.75 Billion INR | 98.829% |
| Bal Pharma Limited | 363.82 Million INR | 91.138% |
| Alkem Laboratories Limited | 400 Million INR | 91.939% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -142.434% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Medicamen Biotech Limited | 12.55 Million INR | -156.82% |
| Unichem Laboratories Limited | 382.22 Million INR | 91.564% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | 70.015% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Valiant Laboratories Limited | 750.89 Million INR | 95.706% |
| Orchid Pharma Limited | 1.2 Billion INR | 97.323% |
| Medico Remedies Limited | 8.67 Million INR | -271.815% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | 71.114% |
| Ipca Laboratories Limited | 5.8 Billion INR | 99.444% |
| Brooks Laboratories Limited | 3.56 Million INR | -804.453% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 2745.1% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.994% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 99.799% |
| NATCO Pharma Limited | 53 Million INR | 39.163% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 98.243% |
| Strides Pharma Science Limited | 6.71 Billion INR | 99.52% |
| Indoco Remedies Limited | 3.51 Billion INR | 99.083% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | 69.753% |